Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epigenetic changes in cancer.

Kirsten Grønbaek1, Christoffer Hother, Peter A Jones

  • 1Department of Hematology, Rigshospitalet, Copenhagen, Denmark. kirsten.groenbaek@rh.regionh.dk

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|November 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same author

Mosaic Chromosomal Alterations Identify Ultra-High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy.

American journal of hematology·2026
Same author

Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS.

Blood neoplasia·2026
Same author

Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.

JAMA oncology·2026
Same author

Validity of The Danish National Chronic Myeloid Neoplasia Registry.

Clinical epidemiology·2026
Same author

Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

British journal of haematology·2026
Same journal

Immune Cell Composition and Prognosis in Node-Positive, Irradiated Breast Cancer Patients in the DBCG-IMN2 Study.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Urinary Secretory-IgA and IgG Responses and Inflammatory Markers in Patients With Pseudomonas aeruginosa Urinary Tract Infections.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

Active Chlorine Antiseptics in Wound Care: Recent Advances and Perspectives for Military Medicine.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

A Review on the Logistics, Financial, Ethical, and Regulatory Frameworks of Artificial Intelligence in Digital Pathology.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Same journal

UE, CT, and ACR TI-RADS Grading in the Combined Diagnosis of Benign and Malignant Thyroid Nodules.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
See all related articles

Epigenetic alterations, heritable changes in gene expression without DNA sequence changes, significantly contribute to cancer development. These modifications, including DNA methylation and histone changes, are potentially reversible and represent promising therapeutic targets.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer arises from accumulated heritable changes in gene function, involving tumor suppressor genes and oncogenes.
  • Both genetic and epigenetic alterations play crucial roles in carcinogenesis.
  • Epigenetic modifications, such as DNA methylation and histone alterations, are increasingly recognized for their impact on cancer development.

Purpose of the Study:

  • To review the contribution of epigenome disruption to cancer.
  • To highlight the potential reversibility of epigenetic modifications in cancer therapy.
  • To discuss the therapeutic implications of targeting epigenetic alterations.

Main Methods:

  • Review of scientific literature on epigenetics and cancer.
  • Analysis of mechanisms of epigenetic alterations (DNA methylation, histone modification).

Related Experiment Videos

  • Discussion of therapeutic strategies targeting epigenetic modifications.

    • Main Results:

    • Epigenetic alterations, including CpG-island methylation in gene promoters, can lead to heritable gene silencing.
    • Unlike genetic mutations, epigenetic changes are potentially reversible.
    • Inhibition of DNA methylation and histone deacetylation can restore gene transcription.

    Conclusions:

    • Disruption of the epigenome is a significant factor in cancer development.
    • Epigenetic modifications offer promising, potentially reversible therapeutic targets for cancer.
    • Epigenetic therapies are advancing, with some already approved for specific hematological and skin cancers.